PHDA testimonials

"Both the PHDA 03 and PHDA 04 courses have made me confident working in ArcGIS, and applying principles of GIS/mapping to population health data and working on spatial analyses. In particular, what has been most helpful about these courses is applying the background theory to surveillance and research questions and walking through the analysis from start to finish, including interpretation of results."

> read full testimonial

"I would definitely recommend this program to my colleagues or others who would like to develop analytical skills and knowledge in data analysis and the use of health data.

I benefited by having an access to various analytic tools and different types/sources of health administrative data. They included a good balance of practice and theory. I did not find these kinds of courses were available to me when I was at University. In addition, I had very practical hands-on practice using statistical analytic tools such as SAS or ArcGIS which are not freely available for public use."

> read full testimonial

"Overall, the PHDA 03 course experience was great. The greatest benefit to me was learning about GIS and practicing the learning through lab assignments with ArcGIS."

> read full testimonial

"The GIS courses, PHDA 03 Population Health and GIS and PHDA 04 Spatial Epidemiology and Outbreak Detection provided the greatest benefits. They were excellent and introduced brand new skills for me. Prior to taking these courses I had some brief exposure to GIS within my Master’s program and through the free online PopData courses. The PHDA 03 and PHDA 04 course labs were very detailed and instructional, offering good balance between theory and practice. The courses generally had enough materials I could take away to continue working independently."

"I found PHDA 03 (Population Health and Geographic Information Systems) very interesting as it provided applicable GIS uses for health services research. I plan on increasingly incorporating GIS analyses in my health services research in order to understand another dimension of care accessibility during the end-of-life phase. "

> read full testimonial